Clinical Trial Update: Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Iparomlimab and Tuvonralimab in combination with chemotherapy for malignant mesothelioma; the study is currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: National Cancer Center, China | Conditions: Malignant Mesothelioma, Mesothelioma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING